ADXN logo

Addex Therapeutics Ltd (ADXN) Cash From Investing

Annual CFI

-$7600.00
-$10.70 K-345.16%

December 1, 2023

Summary

Performance

1-Year Change

-345.16%

3-Year Change

+88.01%

5-Year Change

+86.81%

15-Year Change

-985.71%

ADXN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.78%
ADXN annual cash flow from investing activities is higher than 63.78% of companies in Healthcare sector

High & Low

All-time High

$415.60 K
ADXN annual cash flow from investing activities is currently -101.83% below its historical high of $415.60 thousand

3-Year Low

-$33.20 K

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
ADXN previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
ADXN next annual earnings announcement has not yet been scheduled

OtherADXNcash flowmetrics:

Annual CFF

$5.86 M
ADXN annual cash flow from financing activities is $5.86 million

Annual CFO

-$8.90 M
ADXN annual cash flow from operations is -$8.90 million

Annual FCF

-$8.91 M
ADXN annual free cash flow is -$8.91 million

Annual CAPEX

$7600.00
ADXN annual capital expenditures is $7600.00

Quarterly CFI

$229.70 K
-$4.93 M-95.55%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+960.3%

5-Year Change

+6308.11%

ADXN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.86%
ADXN quarterly cash flow from investing activities is higher than 71.86% of companies in Healthcare sector

High & Low

All-time High

$5.16 M
ADXN quarterly cash flow from investing activities is currently -95.55% below its historical high of $5.16 million

3-Year Low

-$26.70 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ADXN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ADXN next earnings announcement has not yet been scheduled

OtherADXNcash flowmetrics:

Quarterly CFF

$4900.00
ADXN quarterly cash flow from financing activities is $4900.00

Quarterly CFO

-$711.80 K
ADXN quarterly cash flow from operations is -$711.80 thousand

Quarterly FCF

-$713.30 K
ADXN quarterly free cash flow is -$713.30 thousand

Quarterly CAPEX

$1500.00
ADXN quarterly capital expenditures is $1500.00

TTM CFI

$5.39 M
+$230.60 K+4.47%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+16380.66%

5-Year Change

+12488.28%

ADXN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.49%
ADXN TTM cash flow from investing activities is higher than 77.49% of companies in Healthcare sector

High & Low

All-time High

$5.39 M
ADXN TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-$33.10 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ADXN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ADXN next earnings announcement has not yet been scheduled

OtherADXNcash flowmetrics:

TTM CFF

-$40.90 K
ADXN TTM cash flow from financing activities is -$40.90 thousand

TTM CFO

-$6.74 M
ADXN TTM cash flow from operations is -$6.74 million

TTM FCF

-$6.75 M
ADXN TTM free cash flow is -$6.75 million

TTM CAPEX

$2700.00
ADXN TTM capital expenditures is $2700.00

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ADXN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-345.2%0.0%0.0%
3 y3 years+88.0%+960.3%+10000.0%
5 y5 years+86.8%+6308.1%+10000.0%

ADXN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-345.2%+77.1%-95.5%+960.3%at high>+9999.0%
5 y5-year-345.2%+88.0%-95.5%+549.5%at high+8599.8%
alltimeall time-101.8%+99.8%-95.5%+549.5%at high+8599.8%

Addex Therapeutics Ltd Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$229.70 K(-95.5%)
$5.39 M(+4.5%)
Jun 2024
-
$5.16 M(>+9900.0%)
$5.16 M(<-9900.0%)
Mar 2024
-
$0.00(-100.0%)
-$5000.00(-35.1%)
Dec 2023
-$7600.00(-345.2%)
-$1200.00(+33.3%)
-$7700.00(+18.5%)
Sep 2023
-
-$900.00(-69.0%)
-$6500.00(+160.0%)
Jun 2023
-
-$2900.00(+7.4%)
-$2500.00(-725.0%)
Mar 2023
-
-$2700.00(<-9900.0%)
$400.00(-87.1%)
Dec 2022
$3100.00(-109.3%)
$0.00(-100.0%)
$3100.00(-113.1%)
Sep 2022
-
$3100.00(>+9900.0%)
-$23.60 K(-13.2%)
Jun 2022
-
$0.00(0.0%)
-$27.20 K(-8.1%)
Mar 2022
-
$0.00(-100.0%)
-$29.60 K(-10.6%)
Dec 2021
-$33.20 K(-47.6%)
-$26.70 K(+5240.0%)
-$33.10 K(-42.4%)
Sep 2021
-
-$500.00(-79.2%)
-$57.50 K(-1.4%)
Jun 2021
-
-$2400.00(-31.4%)
-$58.30 K(+0.3%)
Mar 2021
-
-$3500.00(-93.2%)
-$58.10 K(-8.4%)
Dec 2020
-$63.40 K
-$51.10 K(+3830.8%)
-$63.40 K(+113.5%)
Sep 2020
-
-$1300.00(-40.9%)
-$29.70 K(-7.5%)
Jun 2020
-
-$2200.00(-75.0%)
-$32.10 K(-4.2%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$8800.00(-49.4%)
-$33.50 K(-23.0%)
Dec 2019
-$43.50 K(-24.5%)
-$17.40 K(+370.3%)
-$43.50 K(+66.7%)
Sep 2019
-
-$3700.00(+2.8%)
-$26.10 K(+16.5%)
Jun 2019
-
-$3600.00(-80.9%)
-$22.40 K(+19.1%)
Mar 2019
-
-$18.80 K
-$18.80 K
Dec 2018
-$57.60 K(+8128.6%)
-
-
Dec 2017
-$700.00(-53.3%)
-
-
Dec 2016
-$1500.00(-100.4%)
-
-
Dec 2015
$415.60 K(+1.7%)
-
-
Dec 2014
$408.60 K(+47.9%)
-
-
Dec 2013
$276.30 K(-215.1%)
-
-
Dec 2012
-$240.00 K(-72.0%)
-
-
Dec 2011
-$858.20 K(-7.6%)
-
-
Dec 2010
-$929.20 K(-74.2%)
-
-
Dec 2009
-$3.60 M(+78.9%)
-
-
Dec 2008
-$2.01 M(+1147.1%)
-
-
Dec 2007
-$161.30 K(-77.6%)
-
-
Dec 2006
-$719.20 K
-
-

FAQ

  • What is Addex Therapeutics Ltd annual cash flow from investing activities?
  • What is the all time high annual CFI for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd annual CFI year-on-year change?
  • What is Addex Therapeutics Ltd quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd quarterly CFI year-on-year change?
  • What is Addex Therapeutics Ltd TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd TTM CFI year-on-year change?

What is Addex Therapeutics Ltd annual cash flow from investing activities?

The current annual CFI of ADXN is -$7600.00

What is the all time high annual CFI for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high annual cash flow from investing activities is $415.60 K

What is Addex Therapeutics Ltd annual CFI year-on-year change?

Over the past year, ADXN annual cash flow from investing activities has changed by -$10.70 K (-345.16%)

What is Addex Therapeutics Ltd quarterly cash flow from investing activities?

The current quarterly CFI of ADXN is $229.70 K

What is the all time high quarterly CFI for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high quarterly cash flow from investing activities is $5.16 M

What is Addex Therapeutics Ltd quarterly CFI year-on-year change?

Over the past year, ADXN quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Addex Therapeutics Ltd TTM cash flow from investing activities?

The current TTM CFI of ADXN is $5.39 M

What is the all time high TTM CFI for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high TTM cash flow from investing activities is $5.39 M

What is Addex Therapeutics Ltd TTM CFI year-on-year change?

Over the past year, ADXN TTM cash flow from investing activities has changed by $0.00 (0.00%)